Filariasis: Clinical Trials

10 trials for Filariasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 2 withdrawn, 1 recruiting. 10 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 410Completed 7, Withdrawn 2, Recruiting 1

Follow Filariasis: new trials by email Literature Review of Filariasis trials Research Report on Filariasis

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Moxidectin Versus Ivermectin as Mass Drug Administration for the Control of Onchocerciasis and Other Neglected Tropical Diseases
Moxidectin, Ivermectin - Onchocerciasis, Ascaris Lumbricoides Infection
Phase 4RecruitingKirby Institute520002025-08-042025-11-21
Cluster RCT of Co-administration Azithromycin, Albendazole & Ivermectin
Administration of Albendazole on Day 1, Administration of Ivermectin on Day 1, Administration of Azithromycin on Day 1 - Trachoma, Lymphatic Filariases
Phase 4CompletedLondon School of Hygiene and Tropical Medicine135112021-12-012022-08-19
Loiasis Cross-reactive Antigenemia and Treatment-related Adverse Events
Ivermectin - Loiasis
Phase 4CompletedWashington University School of Medicine412021-07-302022-09-29
Ivermectin Treatment in Patients With Onchocerciasis-associated Epilepsy
Ivermectin - Ivermectin, Onchocerciasis
Phase 4CompletedRobert Colebunders912017-10-012019-01-07
Twice Yearly Treatment for the Control of LF
400 μg/kg Ivermectin + 400 mg Albendazole - Lymphatic Filariasis, Helminth Infection
Phase 4CompletedNoguchi Memorial Institute for Medical Research14622017-05-192020-02-26
Effect of Concomitant Mansonella Perstans Microfilaremia on Immune Responses Following Single Dose Praziquantel in People With Schistosomiasis
Praziquantel - Schistosomiasis
Phase 4WithdrawnNational Institute of Allergy and Infectious Diseases (NIAID)2016-04-062019-12-17
Safety Study of Combined Azithromycin, Ivermectin and Albendazole for Trachoma and Lymphatic Filariasis
azithromycin, ivermectin, albendazole - Trachoma, Lymphatic Filariasis
Phase 4WithdrawnEmory University2014-02-012014-05-22
Post-treatment Effects of Ivermectin (IVM) or Diethylcarbamazine (DEC) in Loiasis
Diethylcarbamazine, Ivermectin - Loiasis
Phase 4CompletedNational Institute of Allergy and Infectious Diseases (NIAID)1552012-04-012016-11-09
Alternate Chemotherapy Regimens for the Clearance of W.Bancrofti Infection
Diethylcarbamazine, Albendazole, Doxycycline - Filarial; Infestation
Phase 4CompletedIndian Council of Medical Research1462009-02-012013-12-09
Impact of Albendazole -Ivermectin on Wuchereria Bancrofti in Mali
''albendazole'' and ''ivermectin'' - Lymphatic Filariasis
Phase 4CompletedCentre d'Appui à la lutte contre la Maladie11392001-05-012016-05-27

Narrower conditions

Elephantiasis, Filarial (5)  ·  Loiasis (2)  ·  Onchocerciasis (2)  ·  Trachoma (2)  ·  Coinfection (1)  ·  Epilepsy (1)  ·  Hookworm Infections (1)  ·  Neglected Diseases (1)  ·  Parasitic Diseases (1)  ·  Scabies (1)  ·  Schistosomiasis (1)  ·  Trematode Infections (1)  ·  Trichuriasis (1)

Broader conditions

Helminthiasis (10)  ·  Infections (10)  ·  Nematode Infections (10)  ·  Secernentea Infections (10)  ·  Spirurida Infections (10)  ·  Parasitic Diseases (9)  ·  Vector Borne Diseases (6)  ·  Hemic and Lymphatic Diseases (5)  ·  Lymphatic Diseases (5)  ·  Lymphedema (5)  ·  Mosquito-Borne Diseases (5)  ·  Bacterial Infections (2)  ·  Bacterial Infections and Mycoses (2)  ·  Chlamydia Infections (2)

Interventions

Ivermectin (7)  ·  Albendazole (4)  ·  Diethylcarbamazine (2)  ·  Albumins (1)  ·  Azithromycin (1)  ·  Doxycycline (1)  ·  Praziquantel (1)  ·  moxidectin (1)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (2)  ·  Centre d'Appui à la lutte contre la Maladie (1)  ·  Emory University (1)  ·  Indian Council of Medical Research (1)  ·  Kirby Institute (1)  ·  London School of Hygiene and Tropical Medicine (1)  ·  Noguchi Memorial Institute for Medical Research (1)  ·  Robert Colebunders (1)  ·  Washington University School of Medicine (1)

Countries

Cameroon (2)  ·  Angola (1)  ·  Democratic Republic of the Congo (1)  ·  Ethiopia (1)  ·  Ghana (1)  ·  India (1)  ·  Mozambique (1)

Top investigators

Amy D Klion, M.D. (2)  ·  Dziedzom K de Souza, PhD (1)  ·  Huub C Gelderblom, MD, PhD, MPH (1)  ·  Lourduraj J De Britto, M.D (1)  ·  Michel Mandro, MD (1)  ·  Ricardo Thompson, PhD (1)  ·  Susana V Nery, PhD (1)

Results publications

PMID 23981378, PMID 26691247, PMID 28329346, PMID 28855148, PMID 28969715, PMID 31314757, PMID 31923177, PMID 37152362